Related Experiment Video
Updated: Aug 26, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Antihypertensive drug treatment: the potential, expected and observed effects on vascular disease
1Department of Medicine, University of Auckland, New Zealand.
Insights
Modest long-term reductions in diastolic blood pressure significantly lower stroke and coronary heart disease risks. Even a few years of treatment offer substantial benefits for stroke prevention.
Area of Science:
- Cardiovascular epidemiology
- Clinical trials
- Hypertension research
Background:
- Observational studies suggest links between diastolic blood pressure and cardiovascular events.
- Previous estimates of risk reduction may have underestimated the impact of modest blood pressure changes.
Purpose of the Study:
- To re-evaluate the association between long-term diastolic blood pressure differences and the incidence of stroke and coronary heart disease.
- To assess the benefits of antihypertensive drug therapy on stroke and coronary heart disease incidence based on trial data.
Main Methods:
- Re-analysis of prospective observational studies.
- Review and synthesis of results from randomized controlled trials of antihypertensive drug therapy, primarily diuretics.
Main Results:
- A sustained 5-6 mmHg difference in diastolic blood pressure was linked to at least a one-third reduction in strokes and one-fifth fewer coronary heart disease events.
- Antihypertensive therapy achieving similar diastolic blood pressure reductions for a few years largely produced the long-term stroke benefits.
- Treatment significantly reduced coronary heart disease incidence (2P < 0.01), but trial data were insufficient to precisely quantify treatment effects for coronary disease.
Conclusions:
- Modest, sustained reductions in diastolic blood pressure offer significant protection against stroke and coronary heart disease.
- Short-term antihypertensive treatment provides substantial stroke prevention benefits.
- Further research is needed to fully understand the long-term benefits of antihypertensive therapy for coronary heart disease.
Abstract:
Re-analysis of the results of several prospective observational studies indicates that modest long-term differences in usual diastolic blood pressure are associated with larger differences in the primary incidence of stroke and of coronary heart disease than was previously believed. A prolonged difference of 5-6 mmHg in usual diastolic blood pressure was associated with at least one-third fewer strokes and at least one-fifth fewer coronary heart disease events. The results of randomly allocated trials of antihypertensive drug therapy (mostly diuretics) indicate that a similar difference in diastolic blood pressure maintained for just a few years appears to produce much or all of the potential long-term benefits for stroke. The incidence of coronary heart disease was also significantly reduced by treatment (2P less than 0.01). However, for coronary disease, the trial results, even in combination, are inadequate to allow a reliable determination of the size of the treatment effects and the proportion of the long-term potential benefit achieved by a few years of diuretic-based treatment.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension IV: Drug Therapy and Lifestyle Modifications
